医学
丙氨酸转氨酶
天冬氨酸转氨酶
丙氨酸转氨酶
转氨酶升高
内科学
鉴别诊断
转氨酶
胃肠病学
肝损伤
肝功能检查
心肌梗塞
天冬氨酸氨基转移酶
肝损伤
肝硬化
病理
碱性磷酸酶
酶
生物化学
化学
作者
Susan Goorden,Tineke E. Buffart,Annemieke Bakker,Madelon M. Buijs
出处
期刊:PubMed
日期:2013-01-01
卷期号:157 (43): A6443-A6443
被引量:21
摘要
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are commonly used biomarkers for liver damage. As well as in liver tissue, AST is also present in cardiac and skeletal muscle and in erythrocytes, making ALT the most specific marker for liver damage. Here, we describe two patients with sustained increases in ALT and AST levels. The first patient is a 79-year-old woman who developed elevated serum transaminases shortly after having a myocardial infarction. The second patient, an obese 40-year-old woman presented with increased ALT and AST levels in the absence of physical symptoms. Notably, her father died of liver cirrhosis without a history of alcohol abuse. Based upon these case reports we discuss the differential diagnostic work-up of elevated serum transaminase levels. Furthermore, we explain monitoring, test performance, reference values and analytical pitfalls of these biomarkers.
科研通智能强力驱动
Strongly Powered by AbleSci AI